scorecardresearch
Thursday, July 24, 2025
TopicMisleading ads

Topic: misleading ads

Patanjali chyawanprash ad row: Disparaging rival’s product completely impermissible, says Delhi HC

In its advertisement, Patanjali had cautioned consumers against buying chyawanprash which possess 41 Ayurvedic herbs—a fact highlighted by Dabur while promoting its product.

Digital space hosts lion’s share of misleading healthcare ads, majority on sexual wellness

Healthcare sector accounted for a maximum 19% or 1,569 of 8,229 advertisements scrutinised by ASCI during 2023-24. Nearly 86% of drugs found illegal were on digital platforms.

BJP files complaint to ECI for ‘malicious, false, unverified & defamatory’ ads by Congress

In a letter to Election Commission of India, BJP says Congress published ads, just 2 days before polls, with the heading 'Chambu' to portray that Centre has cheated state of Karnataka.

‘What about you?’ At Patanjali hearing, Supreme Court raps IMA for docs ‘advocating’ costly drugs

Top court asserts consumers had a right to know whether they were being misled by FMCG companies too and what agencies were doing to prevent such misuse.

SC praises Ramdev for Yoga work but refuses to let him off in contempt case — ‘not so innocent’

Yoga guru offers to publish a public apology for misleading ads by Divya Pharmacy, saying it 'happened on impulse' and that he would be careful in future.

SC declines apology affidavits of Ramdev, Balakrishnan in Patanjali misleading ads case

In two separate affidavits filed, Ramdev and Balkrishna have tendered an unqualified apology for the 'breach of the statement' recorded in 21 November, 2023 order of the apex court.

Don’t let just Ramdev’s Patanjali take the fall. Allopathy isn’t immune to ‘misleading’ ads

The Indian Medical Association and other allopathic doctors have no moral basis to cast aspersions on Ayurveda or AYUSH companies.

Recommended Patanjali’s Coronil as supporting medicine for COVID, Centre tells SC amid ad row

In an affidavit before the SC, the Union Ayush ministry said it had issued repeated warnings to Patanjali. But it also slams petitioner IMA for ‘denigrating a system of medicine’.   

Patanjali MD Balkrishna apologises to SC over ‘misleading ads’, day after Baba Ramdev is summoned

Acharya Balkrishna says company regrets putting out the publicity campaign that questioned efficacy of modern medicine, but also termed the Drugs & Magic Remedies Act as 'archaic'.

Patanjali misleading ads: SC orders Baba Ramdev, Acharya Balkrishna to be present at next hearing

Indian Medical Association has accused Patanjali of carrying out a smear campaign on evidence-based medicine. Court noted that no response filed by Patanjali on its contempt notice.

On Camera

TV Somanathan’s letter is a reminder—civil servants must roll out the red carpet for investors

The reason that India hasn’t grown at the speed of South Korea, China or Vietnam is because the machinery of the government still holds on to the ‘commanding heights’.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.